CLINICAL TRIALS PROFILE FOR DAPAGLIFLOZIN PROPANEDIOL
✉ Email this page to a colleague
All Clinical Trials for dapagliflozin propanediol
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01944618 ↗ | forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP) | Terminated | Monash University | 2013-10-01 | The study purpose is to assess adverse events in patients with Type 2 diabetes who have newly been prescribed Forxiga for the management of glycemic control | |
NCT01944618 ↗ | forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP) | Terminated | AstraZeneca | 2013-10-01 | The study purpose is to assess adverse events in patients with Type 2 diabetes who have newly been prescribed Forxiga for the management of glycemic control | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dapagliflozin propanediol
Condition Name
Clinical Trial Locations for dapagliflozin propanediol
Clinical Trial Progress for dapagliflozin propanediol
Clinical Trial Phase
Clinical Trial Sponsors for dapagliflozin propanediol
Sponsor Name